Torrey Pines Investment — 2014 Investments

1 investments dated 2014 · listed companies and verified rows first · show all

Avelas Biosciencesavelasbio.comJan 2014 · $6.8M

Clinical-stage drug-device company developing pegloprastide (AVB-620) for real-time surgical margin detection in cancer surgery.

Co-investorsAlexandria

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.